Target intelligence / Profile preview

Oral microbiome modulation

Molecular classification
Other
01

Overview

The oral microbiome is a diverse community of bacteria, fungi, viruses, archaea, and protozoa inhabiting the mouth—all of which interact with each other and with the human host. Modulation strategies, including the use of probiotics, prebiotics, bacterial replacement, antimicrobial agents, and photobiomodulation, aim to restore or maintain a healthy microbial balance. This balance is crucial for oral health (preventing diseases like caries and periodontitis) and also has implications for systemic health, influencing conditions such as diabetes, cardiovascular disease, gastrointestinal disorders, and cancer. Therapeutic modulation focuses on reducing pathogenic microbes while enhancing beneficial commensals through targeted interventions, but it is accompanied by various safety and efficacy considerations.

Other names
Oral microbiota modulationOral microbiome manipulationOral ecosystem modulation
02

Mechanism of action

Promotion of beneficial commensal bacteria; Suppression of pathogenic bacteria (via bacteriocins, competitive exclusion); Biofilm modulation (inhibiting pathogenic biofilm formation)

03

Biological functions

Maintenance of oral homeostasisImmune response regulationPrevention of oral dysbiosisInfluence on systemic health (e.g., cardiovascular, metabolic, gastrointestinal)
04

Disease associations

Infection (periodontal disease, dental caries)Inflammation (periodontitis, systemic inflammatory diseases)Other (potential roles in diabetes, cardiovascular disease, cancer)
05

Safety considerations

Potential for disruption of the native oral microbiome, leading to dysbiosisRisks associated with long-term use of non-indigenous probiotics or antimicrobialsPossible unforeseen systemic effects due to oral-gut microbiome axis manipulation
06

Interacting drugs

Probiotics (e.g., Streptococcus salivarius BLIS K12, BLIS M18)

3 more in the full profile.

07

Biomarkers

Relative abundance of specific pathogens (e.g., Tannerella forsythia, Fretibacterium fastidiosum for periodontitis)Presence of beneficial bacteria (e.g., Streptococcus salivarius)Microbial diversity measures (indicating dysbiosis or healthy state)

Beyond the preview

Go deeper on Oral microbiome modulation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral microbiome modulation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call